Ajinomoto Co. Inc. (TYO:2802) is positioning cutting-edge operations as a driver of future business growth for its contract manufacturing of…...
Please subscribe to read the full story.
antibody drugs
Yokogawa Accelerates Technological Developments in Life Innovation Business
Yokogawa Electric Corp. (TYO:6841) is moving to accelerate its development of technologies geared toward business expansion in the pharmaceutical, food…...
Please subscribe to read the full story.
Yokogawa Spotlights Inline Measurement for Efficient Production of Biologic Antibody Drugs
Yokogawa Electric Corp. (TYO:6841) plans to promote the commercial application of a solution for improving productivity in the manufacture of…...
Please subscribe to read the full story.
